Attorney General Russell Coleman announced Monday that his office had secured $14.4 million in additional settlement dollars from opioid manufacturers.
As part of the agreement, seven of the companies, Alygoen, Amneal, Apotex, Hikma, Mylan, Sun, and Zydus, are prohibited from promoting or marketing opioids and opioid products and making or selling any product that contains more than 40 mg of oxycodone per pill.
Those companies will also be required to create a monitoring and reporting system that would flag suspicious orders, per the release.
An eighth company, Indivior, has agreed not to manufacture or sell opioid products for the next 10 years, but it will be able to continue marketing and selling medications to treat opioid use disorder.
According to Coleman, last month, Kentucky surpassed more than $1 billion in settlement dollars, thanks to a $73.1 million settlement with Purdue Pharma and the Sackler family.
Earlier this year, Coleman also reached a $110 million settlement with Kroger.
According to the system created by Kentucky’s General Assembly, 50% of the settlement funds will be distributed by the Kentucky Opioid Abatement Advisory Commission. The other half of the settlement funds is distributed to cities and counties according to a predetermined formula.
The latest settlement of $14.4 million is part of a larger, $720 million nationwide settlement involving multiple attorneys general’s offices.
Source: WBKO
You must be logged in to post a comment.